MainBusinessBiotechnology and PharmaceuticalsPharmaceuticals › RenaSci Consultancy

RenaSci Consultancy

Edit Page
Report
Scan day: 05 February 2014 UTC
13
Virus safety - good
Description: Pharmaceutical research and development company focused on developing drugs to treat diabetes, obesity and CNS disorders.
Pharmaceutical CRO Consultancy and Experimental Services - Renasci Metabolic Parameters and Biomarkers Hepatic Steatosis and Liver Function Glucocorticoid-induced Insulin Resistance Genetically-predisposed Animals
Size: 213 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Pharmaceutical CRO Consultancy and Experimental Services - Renasci
Keywords:Home
Description:Specialising in Diabetes, Obesity, CNS Techniques and Drug Abuse Testing
IP-address:94.236.34.112

WHOIS Info

NS
Name servers: a.prim-ns.de a.sec-ns.de
WHOIS
Date
Last updated: 20-Mar-2013
Expiry date: 30-Mar-2015